1. Signaling Pathways
  2. GPCR/G Protein
  3. PTHR
  4. PTH2R Isoform

PTH2R

PTH2R (parathyroid hormone 2 receptor) is a class B G protein-coupled receptor that selectively recognizes parathyroid hormone family ligands and functions as the principal receptor for the neuropeptide tuberoinfundibular peptide of 39 residues (TIP39)[1][2]. Upon ligand binding, PTH2R activates G protein-dependent signaling pathways, including cAMP generation and intracellular calcium mobilization, thereby regulating neuroendocrine and cellular responses[3][4]. Mechanistically, the TIP39-PTH2R axis participates in stress adaptation, thermoregulation, nociceptive processing, hormone release, and other central neuroendocrine functions demonstrated in genetic and pharmacological models[5][6]. In cellular systems, PTH2R signaling inhibits proliferation and alters chondrocyte differentiation through modulation of SOX9 expression, supporting a role in skeletal developmental processes[7]. Disease and experimental evidence further links PTH2R signaling to neurobehavioral phenotypes, endocrine regulation, and tissue-specific physiological responses, making the receptor a valuable model for studying peptide GPCR biology[5][6]. Compared with the closely related receptor PTH1R, PTH2R displays distinct ligand selectivity: TIP39 is highly selective for PTH2R, whereas PTHrP exhibits little or weak activity at this receptor, providing a key pharmacological distinction between the two receptor subtypes[2][8][9]. For experimental applications, TIP39 serves as the prototypical endogenous agonist, while peptide antagonists derived from N-terminally truncated TIP39 variants and other receptor-selective ligands have enabled mechanistic investigation of PTH2R signaling, receptor activation, and ligand recognition[4][9][10].

References:

PTH2R Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-P1852
    TIP 39, Tuberoinfundibular Neuropeptide
    Agonist 99.84%
    TIP 39, Tuberoinfundibular Neuropeptide is an endogenous PTH2 receptor agonist and antihypertensive agent. TIP 39, Tuberoinfundibular Neuropeptide selectively activates the PTH2 receptor with no activity on the PTH1 receptor, stimulates cAMP production, activates adenylate cyclase, and elevates intracellular calcium levels via mobilization from intracellular stores. TIP 39, Tuberoinfundibular Neuropeptide is highly conserved in humans, mice, and rats. TIP 39, Tuberoinfundibular Neuropeptide is applicable to research related to nociception and inflammation-induced pain.